Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-25T04:43:37.382Z Has data issue: false hasContentIssue false
  • English
  • Français

Potential for Marketing Costly Medical Technology in Southeast Asia

Published online by Cambridge University Press:  10 March 2009

Cyril Roseman
Cyril Roseman
Affiliation:
University of Hawaii, Manoa
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
World Perspectives
Information
International Journal of Technology Assessment in Health Care , Volume 7 , Issue 1 , Winter 1991 , pp. 106 - 115
Copyright
Copyright © Cambridge University Press 1991

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 These statistics, and all others throughout the article unless otherwise noted, are derived from unpublished U.S. Department of Commerce market data on medical equipment and supplies, especially country market profiles for Southeast Asia.

2 Figley, Melvin M. and Margulis, Alexander R., “The Impact of New Imaging Technology on Health Care, Research, and Teaching: An International Symposium.” American Journal of Radiology, 1987, 149, 1111–26.Google Scholar

3 Singapore domestic production is expected to rise from $33 to $46 million by 1991, an average annual rate of increase of 11%. The bulk of this production comes from Baxter-Travenol, but also includes other manufacturing plants added during the 1980s: Becton-Dickinson, Diagnostic Biotechnology, and Pacific Biomedical. Eighty percent of the domestic Singapore medical equipment and supplies production has been for export, largely Pharmaceuticals, testing equipment, disposables, and patient devices.